NO20030522L - 4-, 5-, 6- og 7-indolderivater, farmasoytiske sammensetninger inneholdende dem og deres anvendelse. - Google Patents

4-, 5-, 6- og 7-indolderivater, farmasoytiske sammensetninger inneholdende dem og deres anvendelse.

Info

Publication number
NO20030522L
NO20030522L NO20030522A NO20030522A NO20030522L NO 20030522 L NO20030522 L NO 20030522L NO 20030522 A NO20030522 A NO 20030522A NO 20030522 A NO20030522 A NO 20030522A NO 20030522 L NO20030522 L NO 20030522L
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
compositions containing
indole derivatives
indole
derivatives
Prior art date
Application number
NO20030522A
Other languages
English (en)
Other versions
NO20030522D0 (no
Inventor
Jan Kehler
Benny Bang-Andersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20030522L publication Critical patent/NO20030522L/no
Publication of NO20030522D0 publication Critical patent/NO20030522D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
NO20030522A 2000-08-18 2003-02-03 4-, 5-, 6- og 7-indolderivater nyttige i behandlingen av CNS- forstyrrelser NO20030522D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001229 2000-08-18
PCT/DK2001/000547 WO2002016349A1 (en) 2000-08-18 2001-08-17 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders

Publications (2)

Publication Number Publication Date
NO20030522L true NO20030522L (no) 2003-02-03
NO20030522D0 NO20030522D0 (no) 2003-02-03

Family

ID=8159658

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030522A NO20030522D0 (no) 2000-08-18 2003-02-03 4-, 5-, 6- og 7-indolderivater nyttige i behandlingen av CNS- forstyrrelser

Country Status (30)

Country Link
US (2) US6958338B2 (no)
EP (1) EP1309586B1 (no)
JP (1) JP2004506731A (no)
KR (1) KR20030022363A (no)
CN (1) CN1243750C (no)
AR (1) AR030357A1 (no)
AT (1) ATE321040T1 (no)
AU (2) AU7961101A (no)
BG (1) BG107611A (no)
BR (1) BR0113452A (no)
CA (1) CA2419266A1 (no)
CZ (1) CZ2003461A3 (no)
DE (1) DE60118205T2 (no)
DK (1) DK1309586T3 (no)
EA (1) EA006155B1 (no)
ES (1) ES2257424T3 (no)
HK (1) HK1059438A1 (no)
HR (1) HRP20030052A2 (no)
HU (1) HUP0302777A2 (no)
IL (1) IL154051A0 (no)
IS (1) IS6694A (no)
MX (1) MXPA03000838A (no)
NO (1) NO20030522D0 (no)
NZ (1) NZ523786A (no)
PL (1) PL363309A1 (no)
PT (1) PT1309586E (no)
SK (1) SK3212003A3 (no)
UA (1) UA74837C2 (no)
WO (1) WO2002016349A1 (no)
ZA (1) ZA200300562B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1988077A4 (en) * 2006-02-23 2009-09-02 Shionogi & Co NUCLEIC HETEROCYCLIC DERIVATIVES SUBSTITUTED BY CYCLIC GROUPS
US10022352B2 (en) 2006-04-07 2018-07-17 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US7645789B2 (en) 2006-04-07 2010-01-12 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
CA2869945C (en) 2006-04-07 2018-01-23 Vertex Pharmaceuticals Incorporated Modulators of atp-binding cassette transporters
US8563573B2 (en) 2007-11-02 2013-10-22 Vertex Pharmaceuticals Incorporated Azaindole derivatives as CFTR modulators
TWI404702B (zh) * 2007-08-31 2013-08-11 Lundbeck & Co As H 兒茶酚胺衍生物和其前藥
US8802868B2 (en) 2010-03-25 2014-08-12 Vertex Pharmaceuticals Incorporated Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
ES2858351T3 (es) 2010-04-22 2021-09-30 Vertex Pharma Compuesto intermedio para proceso de producción de compuestos de cicloalquilcaraboxamido-indol
EP2872122A1 (en) 2012-07-16 2015-05-20 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions of (r)-1-(2,2-diflurorbenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof
JO3425B1 (ar) 2013-07-15 2019-10-20 Novartis Ag مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b
RU2744460C2 (ru) 2014-04-15 2021-03-09 Вертекс Фармасьютикалз Инкорпорейтед Фармацевтические композиции для лечения заболеваний, опосредованных муковисцидозным трансмембранным регулятором проводимости

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421641A1 (de) * 1984-06-09 1985-12-12 Merck Patent Gmbh, 6100 Darmstadt Indolderivate
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
AU6215594A (en) * 1993-03-18 1994-10-11 Merck Sharp & Dohme Limited Indole derivatives as dopamine d4 antagonists
AU694212B2 (en) * 1994-04-28 1998-07-16 Merck Sharp & Dohme Limited Benzofuran derivatives as d4 receptor antagonists
DE19500689A1 (de) * 1995-01-12 1996-07-18 Merck Patent Gmbh Indolpiperidin-Derivate
GB9520731D0 (en) * 1995-10-10 1995-12-13 Merck Sharp & Dohme Therapeutic agents
GB9604036D0 (en) * 1996-02-26 1996-04-24 Merck Sharp & Dohme Therapeutic agents
ATE346050T1 (de) * 1998-01-27 2006-12-15 Aventis Pharma Inc Substituierte oxoazaheterocyclyl faktor xa hemmer
MXPA02003887A (es) * 1999-10-19 2002-09-30 Merck & Co Inc Inhibidores de tirosina cinasa.
US6727264B1 (en) * 2001-07-05 2004-04-27 Synaptic Pharmaceutical Corporation Substituted anilinic piperidines as MCH selective antagonists

Also Published As

Publication number Publication date
UA74837C2 (en) 2006-02-15
CZ2003461A3 (cs) 2003-05-14
AU2001279611B2 (en) 2006-08-10
PT1309586E (pt) 2006-06-30
BR0113452A (pt) 2003-07-15
DE60118205T2 (de) 2006-11-02
WO2002016349A1 (en) 2002-02-28
KR20030022363A (ko) 2003-03-15
CN1447806A (zh) 2003-10-08
CA2419266A1 (en) 2002-02-28
US20030166665A1 (en) 2003-09-04
BG107611A (bg) 2003-12-31
JP2004506731A (ja) 2004-03-04
SK3212003A3 (en) 2003-07-01
EP1309586B1 (en) 2006-03-22
PL363309A1 (en) 2004-11-15
US6958338B2 (en) 2005-10-25
US7105543B2 (en) 2006-09-12
AU7961101A (en) 2002-03-04
ES2257424T3 (es) 2006-08-01
EA006155B1 (ru) 2005-10-27
EA200300278A1 (ru) 2003-06-26
DE60118205D1 (de) 2006-05-11
MXPA03000838A (es) 2003-06-06
AR030357A1 (es) 2003-08-20
US20060004022A1 (en) 2006-01-05
NZ523786A (en) 2005-07-29
CN1243750C (zh) 2006-03-01
EP1309586A1 (en) 2003-05-14
HK1059438A1 (en) 2004-07-02
IS6694A (is) 2003-01-20
IL154051A0 (en) 2003-07-31
ATE321040T1 (de) 2006-04-15
NO20030522D0 (no) 2003-02-03
ZA200300562B (en) 2004-08-23
DK1309586T3 (da) 2006-07-10
HRP20030052A2 (en) 2005-02-28
HUP0302777A2 (hu) 2003-12-29

Similar Documents

Publication Publication Date Title
NO20024175L (no) Azetidinderivater, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene
DK1224170T3 (da) I 6-position substitueret indolin, fremstilling og anvendelse deraf som lægemiddel
NO20031619L (no) Substituerte indoler, farmasöytiske blandinger inneholdende slike indoler og deres anvendelse som PPAR-gamma-bindende midler
DK1337529T3 (da) Heterocyclylalkylpiperidinderivater, deres fremstilling og præparater indeholdende dem
NO20032830D0 (no) Tetrahydropyridinderivater, fremstilling derav og anvendelse som celle-proliferasjonsinhibitorer
NO20052995D0 (no) 1,5-diaryl-pyrrol-3-karboksamid-derivater, og deres anvendelse som kannabinoid reseptormodulatorer.
DK1368349T3 (da) Xanthinderivater, deres fremstilling og deres anvendelse som lægemidler
NO20014013D0 (no) 16-halogenepotilonderivater, fremgangsmater for fremstilling av dem og deres farmasoytiske anvendelse
DK1263721T3 (da) Farmaceutiske sammensætninger, der indeholder 3-aminoazetidinderivater, nye derivater og fremstilling deraf
DK1202733T3 (da) 3(5)-amino-pyrazolderivater, fremgangsmåde til deres fremstilling og deres anvendelse som antitumormidler
NO20014702D0 (no) Diarylderivater og deres anvendelse som medikamenter
DK1083171T3 (da) Pyrazolinderivater, deres fremstilling og anvendelse som medikamenter
NO20042635L (no) 5-Sulfanyl-ñH-1,2,4-triazol-derivater og deres anvendelse som medisin
DK1095025T3 (da) Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
NO20016038L (no) Benzenderivater, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme
NO20024749L (no) Indolin-2-on-derivater, deres fremstilling og anvendelse som ocytocinreseptor-ligander
NO20005146D0 (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
DK1095020T3 (da) 2-Aminopyridinderivater, deres anvendelse som lægemidler og farmaceutiske præparater, der indeholder dem
NO20025150L (no) 2-acylindolderivater og deres anvendelse som antitumormidler
DK1370550T3 (da) Quinolylpropylpiperidinderivater, deres fremstilling og præparater indeholdende dem
NO20031838D0 (no) Benzokazinonderivater, deres fremstilling og anvendelse
NO20030522L (no) 4-, 5-, 6- og 7-indolderivater, farmasoytiske sammensetninger inneholdende dem og deres anvendelse.
NO20030382D0 (no) Nye indolderivater og deres anvendelse som medikamenter
DK1387838T3 (da) Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
DK1228039T3 (da) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmaceutiske præparater, der omfatter dem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
FC2A Withdrawal, rejection or dismissal of laid open patent application